Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer. | J Exp Clin Cancer Res | 2022 | 35016717 | PubTator, text mining | PubMed |
| Identification and validation of the high expression of pseudogene TCAM1P in cervical cancer via integrated bioinformatics analysis. | Cancer Cell Int | 2022 | 35016697 | PubTator, text mining | PubMed |
| Single cell transcriptomic landscape of diabetic foot ulcers. | Nat Commun | 2022 | 35013299 | PubTator, text mining | PubMed |
| Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis. | Stem Cell Res Ther | 2022 | 35012666 | PubTator, text mining | PubMed |
| A novel 14-gene signature for overall survival in lung adenocarcinoma based on the Bayesian hierarchical Cox proportional hazards model. | Sci Rep | 2022 | 34996932 | PubTator, text mining | PubMed |
| In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling. | Gene | 2022 | 34995734 | PubTator, text mining | PubMed |
| Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics. | Theranostics | 2022 | 34987642 | PubTator, text mining | PubMed |
| Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis. | Bioengineered | 2022 | 34978464 | PubTator, text mining | PubMed |
| An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma. | Cancer Sci | 2022 | 34967077 | PubTator, text mining | PubMed |
| APC7 mediates ubiquitin signaling in constitutive heterochromatin in the developing mammalian brain. | Mol Cell | 2022 | 34942119 | PubTator, text mining | PubMed |
| Functional conservation and divergence of the helix-turn-helix motif of E2 ubiquitin-conjugating enzymes. | EMBO J | 2022 | 34942047 | PubTator, text mining | PubMed |
| Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers. | Cancer Res | 2022 | 34911787 | PubTator, text mining | PubMed |
| GH and Senescence: A New Understanding of Adult GH Action. | J Endocr Soc | 2022 | 34909519 | PubTator, text mining | PubMed |
| Research progress of Bub3 gene in malignant tumors. | Cell Biol Int | 2022 | 34882895 | PubTator, text mining | PubMed |
| Temporal proteomics reveal specific cell cycle oncoprotein downregulation by p97/VCP inhibition. | Cell Chem Biol | 2022 | 34847375 | PubTator, text mining | PubMed |
Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex. | Oncogene | 2022 | 34775484 | PubTator, text mining | PubMed |
| Low Cell Number Proteomic Analysis Using In-Cell Protease Digests Reveals a Robust Signature for Cell Cycle State Classification. | Mol Cell Proteomics | 2022 | 34742921 | PubTator, text mining | PubMed |
| Limb-bud and heart development (LBH) contributes to glioma progression in vitro and in vivo. | FEBS Open Bio | 2022 | 34739189 | PubTator, text mining | PubMed |
| Proteasome inhibition alters mitotic progression through the upregulation of centromeric α-Satellite RNAs. | FEBS J | 2022 | 34739170 | PubTator, text mining | PubMed |
| Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer. | Cancer Res | 2022 | 34711612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=33